Summary & Overview
HCPCS Level II M1321: Post-Injection Ophthalmic Follow-Up Documentation
HCPCS Level II code M1321 documents patients who were not seen for follow-up within seven weeks after an ocular injection or who lack documented intraocular pressure (IOP) or a care plan when IOP exceeded 25 mm Hg. This code captures gaps in post-injection monitoring and documentation that are important for patient safety and quality oversight across ophthalmology and outpatient specialty practices. Nationally, consistent post-injection follow-up is critical to detect complications such as elevated IOP or infection, making accurate coding relevant for clinical quality measurement and administrative reviews. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what M1321 represents, the clinical and operational context for use, and which payers are typically considered in coverage and administrative comparisons. The publication outlines expected service type and typical sites of service, notes common documentation scenarios reflected by the code, and indicates where input data is not available. Data elements such as specific payer policies, associated taxonomies, ICD-10 diagnoses, related codes, and service line details are not provided in the input.
Billing Code Overview
HCPCS Level II code M1321 describes patients who were not seen within seven weeks following the date of an injection for follow-up, or patients who did not have a documented intraocular pressure (IOP) or lacked a documented plan of care when the IOP exceeded 25 mm Hg.
Service type: Follow-up assessment and documentation related to post-injection ocular care.
Typical site of service: Ophthalmology clinic or outpatient specialty practice where intravitreal or periocular injections are administered and postoperative follow-up is expected.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical scenario involves an adult patient who received an intraocular injection (e.g., intravitreal anti-VEGF or steroid) for macular degeneration, diabetic macular edema, retinal vein occlusion, or intraocular inflammation. The procedure is performed in an ambulatory ophthalmology clinic or ambulatory surgery center. Standard post-injection workflow includes documentation of the intraocular pressure (IOP) immediately post-injection and scheduled follow-up within 4–7 weeks. This billing code, M1321, applies when the patient was not seen within seven weeks after the injection or when there is no documented IOP or no documented plan of care despite an IOP >25 mmHg. A realistic patient scenario: a 72-year-old patient receives an intravitreal anti-VEGF injection for neovascular age-related macular degeneration in clinic; the immediate post-injection IOP was not entered into the electronic health record, and the patient misses the planned 4-week follow-up, returning after 10 weeks with elevated IOP and no interim plan documented. Typical sites of service: ambulatory ophthalmology clinic, retinal specialty clinic, or ambulatory surgery center. Typical clinicians involved: retina specialist (ophthalmologist), ophthalmic technician, and clinic nursing staff responsible for post-procedure measurements and follow-up scheduling.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural service |